• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Stock

Pfizer CEO says tariff uncertainty is deterring further U.S. investment in manufacturing, R&D

by April 29, 2025
written by April 29, 2025

Pfizer CEO Albert Bourla on Tuesday said uncertainty around President Donald Trump’s planned pharmaceutical tariffs is deterring the company from further investing in U.S. manufacturing and research and development. 

Bourla’s remarks on the company’s first-quarter earnings call came in response to a question about what Pfizer wants to see from tariff negotiations that would push the company to increase investments in the U.S. It comes as drugmakers brace for Trump’s levies on pharmaceuticals imported into the country — his administration’s bid to boost domestic manufacturing.

“If I know that there will not be tariffs … then there are tremendous investments that can happen in this country, both in R&D and manufacturing,” Bourla said on the call, adding that the company is also hoping for “certainty.”

“In periods of uncertainty, everybody is controlling their cost as we are doing, and then is very frugal with their investment, as we are doing, so that we are prepared for remit. So that’s what I want to see,” Bourla said.

Bourla noted the tax environment, which had previously pushed manufacturing abroad, has “significantly changed now” with the establishment of a global minimum tax of around 15%. He said that shift hasn’t necessarily made the U.S. more attractive, saying “it’s not as good” to invest here without additional incentives or clarity around tariffs.

“Now [Trump] I’m sure — and I know because I talked to him — that he would like to see even a reduction in the current tax regime particularly for locally produced goods,” Bourla said, adding a further decrease would be would be a strong incentive for manufacturing in the U.S.

Unlike other companies grappling with evolving trade policy, Pfizer did not revise its full-year outlook on Tuesday. However, the company noted in its earnings release that the guidance “does not currently include any potential impact related to future tariffs and trade policy changes, which we are unable to predict at this time.”

But on the earnings call on Tuesday, Pfizer executives said the guidance does reflect $150 million in costs from Trump’s existing tariffs.

“Included in our guidance that we didn’t really speak about is there are some tariffs in place today,” Pfizer CFO Dave Denton said on the call.

“We are contemplating that within our guidance range and we continue to again trend to the top end of our guidance range even with those costs to be incurred this year,” he said.

This post appeared first on NBC NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Gorsuch scolds Supreme Court litigator in rare, heated exchange
next post
Dem governor blasts Trump, Musk in new attack campaign as 2028 buzz grows

related articles

FCC greenlights Paramount’s $8 billion merger with entertainment...

July 25, 2025

Microsoft’s Satya Nadella says job cuts have been...

July 25, 2025

Alphabet beats earnings expectations, raises spending forecast

July 24, 2025

UnitedHealth says it faces DOJ investigation over Medicare...

July 24, 2025

Uber will let women drivers and riders request...

July 24, 2025

UnitedHealth says it is facing DOJ investigation over...

July 24, 2025

Businesses are cautiously spending on corporate travel as...

July 23, 2025

Lawsuit says Clorox hackers got passwords simply by...

July 23, 2025

Credit card startup Imprint beats big banks for...

July 23, 2025

Orange juice importer says Brazil tariffs will squeeze...

July 22, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • USDCAD and USDCNH: USDCAD continues to slide to a new low

    August 22, 2024
  • Trump says he’ll drop sanctions on Syria in move to normalize relations

    May 13, 2025
  • Dogecoin and Shiba Inu: Dogecoin drops to a new weekly low

    July 23, 2024
  • Household savings are thinning. Here’s how to put money back in your pocket.

    July 22, 2024
  • GOP bill takes aim at Congress’ ‘no rules apply’ emergency spending

    June 5, 2025

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 5

    Biden calls to ‘lower the temperature’ then bashes Trump in NAACP speech

    July 17, 2024

Categories

  • Economy (829)
  • Editor's Pick (5,526)
  • Investing (634)
  • Stock (858)

Latest Posts

  • Israel’s Netanyahu reacts after Trump warns of ‘hell to pay’ if Hamas doesn’t free hostages

    December 3, 2024
  • Companies are slashing prices to woo consumers. It’s working.

    July 28, 2024
  • Dozens of House lawmakers rally around funding Afghan visa program as Trump vows major spending cuts

    December 24, 2024

Recent Posts

  • Turkish tourists flock to Greece amid skyrocketing inflation at home

    July 22, 2024
  • Netanyahu says security in Gaza is critical to stop Hamas smuggling hostages into Iran: ‘lost forever’

    September 6, 2024
  • How Donald Trump sneaked up on me and a bunch of new friends in Milwaukee

    July 23, 2024

Editor’s Pick

  • New Trump-aligned committee chair pledges ‘colonoscopy’ of State Department spending

    December 11, 2024
  • Biden’s woes converge: Last-minute pardons under fire, calls for prosecution mount following Hur tape release

    May 18, 2025
  • Dow rises 200 points to close at a record

    July 17, 2024
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock